tradmap

CELZ CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

$1.05 -7.46%

Updated

Healthcare · Biological Products, (No Diagnostic Substances)

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $7 million. Shares last traded at $1.05, 83.0% below their 52-week high. Over the past year the stock is down 63.2%. Revenue declined 45.5% year over year.

Market Cap
$7M
Shares Out
6.6M
EPS (TTM)
$-4.15
P/E Ratio
P/S Ratio
2318.38
P/B Ratio
0.80
Dividend / Share
Dividend Yield
52-Week High
$6.20
52-Week Low
$0.63
Volume
9,355
Avg Vol (3m)
186,107.048

Performance

1W
-7.86%
1M
+18.54%
3M
-51.61%
6M
-42.97%
YTD
-46.98%
1Y
-63.24%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
44.75
SMA (50)
$1.03
SMA (200)
$2.03
Price vs SMA50
+1.97%
Price vs SMA200
-48.10%
ATR (14)
$0.14

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$0M
Net Income
$-6M
Gross Margin
66.9%
Operating Margin
Net Margin
Return on Equity
-69.8%
Return on Assets
-64.4%
Current Ratio
12.91
Debt / Equity
0.59
Revenue Growth (YoY)
-45.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-0.79 2026-08-07
Q1 2026 $-0.38 2026-05-08
FY 2025 $-2.52 2026-03-20
Q3 2025 $-1.72 2025-11-07
Q2 2026 $-1.26 2026-08-07
Q1 2026 $-0.83 2026-05-08

Full earnings history →

Biological Products, (No Diagnostic Substances) peers

CELZ vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap. Updated

P/S vs peers
2318.38 / 19.49 med
+11793% premium
1–14 of 14
AMGNAmgen$240.1B27.476.3023.0%+0.31%
GILDGilead Sciences$187.5B-57.876.16-10.6%+1.09%
MRNAModerna$58.8B-18.68-1.94%
RVMDRevolution Medicines, Inc.$45.2B-25.55+0.76%
BIIBBiogen$33.1B24.163.3413.8%+0.78%
NBIXNeurocrine Biosciences Inc$16.1B22.814.7720.9%+0.33%
EXELExelixis, Inc.$14.7B17.036.0235.3%+1.00%
HALOHalozyme Therapeutics, Inc.$12.6B30.397.5524.9%+1.01%
TECHBio-Techne$11.4B62.489.3515.0%+0.21%
KRYSKrystal Biotech, Inc.$11.0B45.5224.9554.8%+0.58%
APGEApogee Therapeutics, Inc.$10.2B-34.57+0.04%
KYMRKymera Therapeutics, Inc.$9.7B-32.51-1.24%
RGENRepligen Corp$9.6B230.5312.205.3%-1.87%
PCVXVaxcyte, Inc.$9.1B-8.56-0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.